| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-11-21 |
4 |
AS |
$13.45 |
$11,042 |
D/D |
(821) |
454,242 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-02-24 |
4 |
AS |
$13.56 |
$2,861 |
D/D |
(211) |
436,598 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-08-23 |
4 |
AS |
$13.64 |
$2,810 |
D/D |
(206) |
410,087 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-06-05 |
4 |
AS |
$13.70 |
$54,800 |
D/D |
(4,000) |
592,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-08-21 |
4 |
AS |
$13.78 |
$2,908 |
D/D |
(211) |
410,293 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-02-28 |
4 |
AS |
$13.85 |
$2,521 |
D/D |
(182) |
367,498 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-05-21 |
4 |
AS |
$13.87 |
$2,927 |
D/D |
(211) |
410,894 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-05-23 |
4 |
AS |
$13.90 |
$2,891 |
D/D |
(208) |
410,686 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-05-29 |
4 |
AS |
$13.93 |
$2,535 |
D/D |
(182) |
410,504 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-06-01 |
4 |
AS |
$14.06 |
$84,493 |
D/D |
(6,000) |
596,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-08-28 |
4 |
AS |
$14.35 |
$2,612 |
D/D |
(182) |
409,905 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-11-22 |
4 |
AS |
$14.40 |
$3,269 |
D/D |
(227) |
454,015 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-20 |
4 |
AS |
$14.47 |
$3,140 |
D/D |
(217) |
424,986 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-03-09 |
4 |
AS |
$14.83 |
$481,411 |
D/D |
(32,462) |
442,276 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-28 |
4 |
AS |
$14.90 |
$2,712 |
D/D |
(182) |
411,105 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-23 |
4 |
AS |
$14.90 |
$3,159 |
D/D |
(212) |
424,774 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-11-23 |
4 |
AS |
$14.97 |
$1,542 |
D/D |
(103) |
402,088 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-11-28 |
4 |
AS |
$14.97 |
$2,725 |
D/D |
(182) |
401,906 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-11 |
4 |
S |
$15.00 |
$244,332 |
D/D |
(16,279) |
546,533 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-12 |
4 |
S |
$15.00 |
$746,818 |
D/D |
(49,771) |
496,762 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-13 |
4 |
S |
$15.00 |
$513,388 |
D/D |
(33,950) |
462,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-11-21 |
4 |
AS |
$15.01 |
$3,182 |
D/D |
(212) |
402,403 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-09-17 |
4 |
AS |
$15.02 |
$58,578 |
D/D |
(3,900) |
326,705 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-09-16 |
4 |
AS |
$15.07 |
$167,277 |
D/D |
(11,100) |
330,605 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-02-23 |
4 |
AS |
$15.09 |
$1,539 |
D/D |
(102) |
475,475 |
0 |
- |
|
173 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
